Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon

Carcinogenesis

Volumn 14, Issue 11, 1993, Pages 2219-2225

  Rao, Chinthalapally V ^a   Simi, Barbara ^a   Reddy, Bandaru S ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CURCUMIN; HYDROXYICOSATETRAENOIC ACID; LIPOXYGENASE; ORNITHINE DECARBOXYLASE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PROTEIN TYROSINE KINASE; THROMBOXANE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; COLON; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; INTESTINE CRYPT; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT;

ANIMAL; ARACHIDONIC ACID; AZOXYMETHANE; COLON; CURCUMIN; DIET; ENZYME INDUCTION; INTESTINAL MUCOSA; LIPOXYGENASE; LIVER; MALE; ORNITHINE DECARBOXYLASE; PROTEIN-TYROSINE KINASE; RATS; RATS, INBRED F344; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027333082     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/14.11.2219     Document Type: Article

References (50)

1. Ammon, H.P.T. and Wahl, M.A. (1991) Pharmacology of Curcuma longa. Planta Med., 57, 1-7.
2. Nadkarani, K.M. (1976) Curcuma longa. In Nadkarani, K.M. (ed.) India Materia Medico. Popular Prakashan Publishing Co., Bombay, pp. 414-416.
3. Tonnesen, H.H. (1992) Chemistry of curcumin and curcuminoids. In Ho, C.-T., Lee, C.Y. and Huang,M.-T. (eds) Phenolic Compounds in Food and their Effect on Health, Vol. 1: Analysis, Occurrence and Chemistry, ACS Symposium Series No. 506. American Chemical Society, Washington, DC, pp. 143-153.
4. Srimal, R.C. and Dhawan, B.N. (1973) Pharmacology of diferuloylmethane (curcumin), a non-steroidal antiinflammatory agent. J. Pharm. Pharmacol., 25, 447-452.
5. Satoskar, R.R., Shah, S.J. and Sbenoy, S.G. (1986) Evaluation of antiinflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int. J. Clin. Pharmacol Ther. Toxicol., 24, 651-654.
6. Sharma, O.P. (1976) Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol., 25, 1811-1812.
7. Toda, S., Miyase, T., Arichi, H., Tanizawa, H. and Taldno, Y. (1985) Natural antioxidants HI. Antioxidative components isolated from rhizome of Curcuma longa L. Chem. Pharm. Bull, 33, 1725-1728.
8. Huang, M.-T., Smart, R.C., Wong, G.-Q. and Conney, A.H. (1988) Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-0-tetradecanoylpborbol-13-acetate. Cancer Res., 48, 5941-5946.
9. Huang, M.-T., Lysz, T., Ferraro, T., Abidi, T.F., Lasldn, J.D. andCotmey, A.H. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res., 51, 813-819.
10. Huang, M.-T., Wang, Z.Y., Georgiadis, C.A., Laskin, J.D. and Cormey, A.H. Inhibitory effect of curcumin on tumor initiation by benzo[a]pyrene and 7, 12-dimethylbenz[a]anthracene. Carcinogenesis, 13, 2183-2186.
11. Azuine, M.A. and Bhide, S.V. (1992) Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr. Cancer, 17, 77-83.
12. Huang, M.-T., Lysz, T., Ferraro, T. and Cotmey, A.H. (1992) Inhibitory effects of curcumin on tumor promotion and arachidonic acid metabolism in mouse epidermis. In Wallenberg, L., Lipkin, M., Boone, C.W. and Kelloff, G.J. (eds), Cancer Chemoprevention. CRC Press, Boca Raton, FL, pp. 375-391.
13. Huang, T.-S., Lee, S.-C. and Lin, J.-K. (1991) Suppression of c-JunJAP-l activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc. Natl Acad Sci. USA, 88, 5292-5296.
14. Reddy, B.S., Tokumo, K., Kulkami, N., Aliaga, C. and Kelloff, G. (1992) Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis, 13, 1019-1023.
15. Boring, C.C., Squires, T.S. and Tong, T. (1993) Cancer Statist., 43, 7-26.
16. National Research Council. (1982) Inhibitors of carcinogenesis. In Diet, Nutrition and Cancer. National Academy Press, Washington, DC, pp. 358-370.
17. Wynder, E.L., Kajitani, T., Ishikawa, S., Dodo, H. and Takano, A. (1969) Environmental factors in cancer of colon and rectum. Cancer, 23, 1210-1220.
18. Reddy, B.S. (1986) Diet and colon cancer: evidence from human and animal model studies. In Reddy, B.S. and Cohen, L.A. (eds), Diet, Nutrition and Cancer: A Critical Evaluation. CRC Press, Boca Raton, FL, pp. 47-65.
19. Ames, B.N. (1983) Overview: food constituents as a source of mutagens, carcinogens, and anticarcinogens. In Knudsen, J.B. (ed.) Genetic Toxicology of the Diet. Alan R. Liss Inc., New York, p. 3.
20. Wattenberg, L.W. (1992) Chemoprevention of cancer by naturally occurring and synthetic compounds. In Wattenberg, M., lipkin, C.W., Boone, C.W. and Kelloff, G.J. (eds) Cancer Chemoprevention. CRC Press, Boca Raton, FL, pp. 19-39.
21. Pegg, A.E. (1988) Polyamine metabolism and its importance in neoplastic growth as a target for chemotherapy. Cancer Res., 48, 759-774.
22. Hunter, T. and Cooper J.A. (1985) Protein tyrosine kinases. Annu. Rev. Biochem., 54, 897-930.
23. Gazh, A., Yaish, P., Gilon, C. and Levitzki, A. (1989) Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem., 32, 2344-2352.
24. McLellan, E.A. and Bird, R.P. (1988) Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res., 48, 6187-6192.
25. Tuduk, B., Bird, R.P. and Bruce, W.R. (1989) Foci of aberrant crypts in the colon of mice and rats exposed to carcinogens associated with foods. Cancer Res., 49, 1236-1240.
26. Wargovich, M.J., Yang, E., Preston, R., and Palmer, C. (1993) Prevention of aberrant crypt growth in rat colon by Don-steroidal anti-inflammatory drugs (NSAIDs). Proc. Am. Assoc. Cancer Res., 34, 125.
27. Steele, V.W. and Kelloff, G.J. (1993) Evaluation of a rat colon crypt assay to identify chemopreventive agents compared to rodent colon tumor assay systems. Proc. Am. Assoc. Cancer Res., 34, 552.
28. Fiala, E.S. (1977) Investigations into the metabolism and mechanisn of action of the colon carcinogens 1, 2-dimethylhydrazine and azoxymethane. Cancer, 2436-2445.
29. Rao, C.V., Desai, D., Kaul, B., Amin, S. and Reddy, B.S. (1992) Effect of caffeic arid esters on carcinogen-induced mutagenicity and human colon adenocarcinoma cell growth. Chem.-Biol. Interact., 84, 277-290.
30. Fischer, S.M., Baldwin J.K., Jasheway, R.W., Patrick, C E. and Cameron, G.S. (1988) Phorbol ester induction of 8-lipoxygenase in inbred SENCAR (SSIN) but not C57BL/6J mice correlated with hyperplasia, edema, and oxidant generation but not ornithine decarboxylase induction. Cancer Res., 48, 658-664.
31. Lysz, T.W. and Needleman, P. (1982) Evidence for two forms of fatty acid cyclooxygenase in brain. J. Neurochem., 38, 1111-1117.
32. Takano, S., Matsushima, M., Eturk E. and Bryan, G.T. (1981) Early induction of rat colonic epithelia ornithine and 5-adenosyl-1-methionine decarboxylase activities by N-methyl-N’-nitro-W-nitroguankline or bile salts. Cancer Res., 624-628.
33. Verma, A.K., Ashendel, C.L. and Boutwell, R.K. (1980) Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandin and tumor promotion caused by TP A. Cancer Res., 40, 708-715.
34. Lu, Y.-P., Chang, R.L., Huang, M.-T. and Conney, A.H. (1993) Inhibitory effect of curcunfin on 12-O^etradecanoylphcrrbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis, 14, 293-297.
35. Giordano, S., Direnzo, M.F., Cirilko, D., Naldini, L., Chiado’piat, L. and Comoglio, P.M. (1987) Protein pbosphorylated on tyrosine as markers of human tumor cell lines. Int. J. Cancer, 38, 482-487.
36. Tbompson, J.F. (1988) Specific receptors for epidermal growth factor in rat intestinal microvillus membranes. Am. J. Physiol., 254, 429-435.
37. Ulsben, M.H., Lyn-Cook, L.E. and Raasch, R.H. (1986) Effect of intraluminal epidermal growth factor on mucosal proliferation in the small mtesme of adult rats. Gastroenterology, 91, 1134-1140.
38. Umazawa, H., Imoto, M., Sawa, T., Isshilri, K., Matsuda, N., Uchida, T., Linuma, H., Hamada, M. and Takeuchi, T. (1986) Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstain, produced by MH435-hF3. J. Antibiot., 39, 170-173.
39. Powis, G. (1991) Signalling targets for anticancer drug development. Trends Pharmacol. Sci., 12, 188-194.
40. Spector, A.A., Gordon, J.A. and Moore, S.A. (1988) Hydroxyeicosatetiaenoic acids (HETEs). Prog. Lipid Res., 27, 271-323.
41. Horm, K.V., Grossi, I.M., Steinert, B.W., Chopra, JL., Onoda, J., Nelson, K.K. and Taylor, J.D. (1989) Lipoxygenase regulation of membrane expression of tumor cell glycoproteins and subsequent metastasis. Adv. Prostaglandin Thromboxane Leukotriene Res., 19, 439-443.
42. Timer, J., Chen, Y.Q., Liu, B., Bazar, R., Taylor J.D. and Hotm, K.V. (1992) The lipoxygenase metabolite 12(S)-HETE promotes alpha nb beta 3 integrin-mediated tumor-cell spreading on fibronectin. Int. J. Cancer, 52, 594-603.
43. Fiirstenbueger, G., Schurich, B., Kaina, B., Petmsevska, R.T., Fusenig, N.E. and Marks, F. (1989) Tumor induction in initiated mouse skin by phorbol esters and methyhnethanesulfbnate: correlation between chromosomal damage and conversion (‘stage I of tumor promotion’) in vivo. Carcinogenesis, 10, 749-752.
44. Verma, A.K., Ashendel, C.L. and Boutwell, R.K. (1980) Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoyl-phorbol-13-acetate. Cancer Res., 40, 208-215.
45. Metzger, U., Meier, I., Uhlschmid, G. and Weihe, H., Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer. Dis. Colon Rectum, 27, 366-369.
46. Flynn, K.L., Rafferty, M.F. and Boctor, A.M. (1986) Inhibition of 5-hydroxyeicosatetraenoic acid (5-Hfc'fE) formation in intact fnnnan neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leuk. Med., 22, 357-360.
47. Shih, C.-A. and Lin, J.-K. (1993) Inhibition of 8-hydroxydeoxyguanosine formation by curcumin in mouse fibroblast cells. Carcinogenesis, 14, 709-712.
48. Predow, T.P., Barrow, B.J., Ashton, W.S., O’Riordan, M.A., Pretlow, T.G., Jurcisek, J.A. and Stellato, T.A. (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res., 51, 1564-1567.
49. Huang, M.-T., Deschner, E.E., Newmark, H.L., Wang, Z.Y., Ferraro, T.A. and Conney, A.H. (1992) Effect of dietary curcumin and ascorbyl palmhate on azoxymethanol-induced colonic epithelia cell proliferation and focal areas of dysplasia. Cancer Lett., 64, 117-121.
50. Huang, M.T., Ma, W., Lou, Y.-R., Ferraro, T., Reuhl, K., Newmark, H. and Conney, A.H. (1993) Inhibitory effect of dietary curcumin on gastrointestinal tumorigenesis in mice. Proc. Am. Assoc. Cancer Res., 34, 555.